Agnetti Giulio, Kaludercic Nina, Kane Lesley A, Elliott Steven T, Guo Yurong, Chakir Khalid, Samantapudi Daya, Paolocci Nazareno, Tomaselli Gordon F, Kass David A, Van Eyk Jennifer E
Johns Hopkins Bayview Proteomics Center, Baltimore, MD 21224, USA.
Circ Cardiovasc Genet. 2010 Feb;3(1):78-87. doi: 10.1161/CIRCGENETICS.109.871236. Epub 2009 Nov 17.
Cardiac resynchronization therapy (CRT) improves chamber mechanoenergetics and morbidity and mortality of patients manifesting heart failure with ventricular dyssynchrony; however, little is known about the molecular changes underlying CRT benefits. We hypothesized that mitochondria may play an important role because of their involvement in energy production.
Mitochondria isolated from the left ventricle in a canine model of dyssynchronous or resynchronized (CRT) heart failure were analyzed by a classical, gel-based, proteomic approach. Two-dimensional gel electrophoresis revealed that 31 mitochondrial proteins where changed when controlling the false discovery rate at 30%. Key enzymes in anaplerotic pathways, such as pyruvate carboxylation and branched-chain amino acid oxidation, were increased. These concerted changes, along with others, suggested that CRT may increase the pool of Krebs cycle intermediates and fuel oxidative phosphorylation. Nearly 50% of observed changes pertained to subunits of the respiratory chain. ATP synthase-beta subunit of complex V was less degraded, and its phosphorylation modulated by CRT was associated with increased formation (2-fold, P=0.004) and specific activity (+20%, P=0.05) of the mature complex. The importance of these modifications was supported by coordinated changes in mitochondrial chaperones and proteases. CRT increased the mitochondrial respiratory control index with tightened coupling when isolated mitochondria were reexposed to substrates for both complex I (glutamate and malate) and complex II (succinate), an effect likely related to ATP synthase subunit modifications and complex quantity and activity.
CRT potently affects both the mitochondrial proteome and the performance associated with improved cardiac function.
心脏再同步治疗(CRT)可改善心室不同步的心衰患者的心腔机械能量学、发病率和死亡率;然而,对于CRT获益背后的分子变化知之甚少。我们推测线粒体可能因其参与能量产生而发挥重要作用。
采用经典的基于凝胶的蛋白质组学方法,分析从不同步或再同步(CRT)心力衰竭犬模型的左心室分离出的线粒体。二维凝胶电泳显示,在错误发现率控制在30%时,有31种线粒体蛋白发生了变化。回补途径中的关键酶,如丙酮酸羧化和支链氨基酸氧化,有所增加。这些协同变化以及其他变化表明,CRT可能会增加三羧酸循环中间产物的储备并促进氧化磷酸化。观察到的变化中近50%与呼吸链亚基有关。复合物V的ATP合酶β亚基降解减少,其由CRT调节的磷酸化与成熟复合物的形成增加(2倍,P = 0.004)和比活性增加(+20%,P = 0.05)相关。线粒体伴侣蛋白和蛋白酶的协同变化支持了这些修饰的重要性。当分离的线粒体重新暴露于复合物I(谷氨酸和苹果酸)和复合物II(琥珀酸)的底物时,CRT通过加强偶联增加了线粒体呼吸控制指数,这种效应可能与ATP合酶亚基修饰以及复合物数量和活性有关。
CRT对线粒体蛋白质组以及与改善心脏功能相关的性能都有显著影响。